Product
DA-5207
1 clinical trial
1 indication
Indication
HealthyClinical trial
An Open-label, Randomized, Cross-over, Multiple Dose, Phase 1 Clinical Trial to Evaluate the Safety, Pharmacokinetics and Pharmacodynamics of DA-5207 Transdermal Delivery System in Healthy AdultsStatus: Completed, Estimated PCD: 2022-12-13